INNOVATIVE ESTHETICS AND HOSPITAL HEALTHCARE
|
Q-Med is a medical device Group that primarily develops, manufactures, markets and sells medical implants.
Esthetics
Q-Med develops products that improve the appearance. When someone experiences a heightened sense of well-being, greater self-esteem or a greater quality of life with the aid of our products, that is beauty for us.
Hospital healthcare
Several of Q-Med's products have been the first on the market. Most of the products are based on the company's patented technology, NASHA™, for the production of stabilized non-animal hyaluronic acid.
The company today has approximately 650 co-workers in 20 countries, with almost 400 at the company's head office and production facility in Uppsala. Q-Med AB is listed in the Mid Cap segment of the NASDAQ OMX Nordic.
|
|
|
|
|
|
Q-Med's half-year report January-June 2010
|
|
|
|
|
|
Uppsala April 27, 2010
Maria Carell will succeed Bengt Ågerup as CEO of Q-Med AB on September 1, 2010.
Maria comes from Actavis, where she has successfully built up the Swedish business since 2005. Bengt Ågerup will continue as CEO until Maria Carell takes up her appointment.
|
 Read more
|
|
|
|
|
|
|
QMED 30/07/2010 11:10:07
-0.77% -0.50 sek, Vol: 8,585
Last: 64.75 sek
High: 64.75 sek Low: 64.50 sek
The Q-Med share
|
|
|
|
|
|
|